ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $4.90M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$135.42
Trade value
$1.29M
% of position
Common Stock
Shares
−239.00
Price / share
$509.48
Trade value
$121.77K
% of position
Common Stock
Shares
−231.00
Price / share
$510.47
Trade value
$117.92K
% of position
Common Stock
Shares
−170.00
Price / share
$511.59
Trade value
$86.97K
% of position
Common Stock
Shares
−439.00
Price / share
$513.06
Trade value
$225.23K
% of position
Common Stock
Shares
−1.26K
Price / share
$514.18
Trade value
$649.92K
% of position
Common Stock
Shares
−2.33K
Price / share
$514.99
Trade value
$1.20M
% of position
Common Stock
Shares
−1.88K
Price / share
$516.04
Trade value
$970.16K
% of position
Common Stock
Shares
−873.00
Price / share
$517.09
Trade value
$451.42K
% of position
Common Stock
Shares
−1.63K
Price / share
$518.19
Trade value
$844.64K
% of position
Common Stock
Shares
−441.00
Price / share
$518.65
Trade value
$228.72K
% of position
Net shares
+0.00
Net value
-$3.61M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/18/2026 | M · Option Exercise | +9.50K | $135.42 | $1.29M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −239.00 | $509.48 | $121.77K | 0.1% | 333.94K | 333.70K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −231.00 | $510.47 | $117.92K | 0.1% | 333.70K | 333.47K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −170.00 | $511.59 | $86.97K | 0.1% | 333.47K | 333.30K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −439.00 | $513.06 | $225.23K | 0.1% | 333.30K | 332.86K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −1.26K | $514.18 | $649.92K | 0.4% | 332.86K | 331.60K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −2.33K | $514.99 | $1.20M | 0.7% | 331.60K | 329.27K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −1.88K | $516.04 | $970.16K | 0.6% | 329.27K | 327.39K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −873.00 | $517.09 | $451.42K | 0.3% | 327.39K | 326.51K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −1.63K | $518.19 | $844.64K | 0.5% | 326.51K | 324.88K |
| Common Stock Indirect | 8/18/2026 | S · Sale | −441.00 | $518.65 | $228.72K | 0.1% | 324.88K | 324.44K |
| Total | +0.00 | -$3.61M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
135.42
Held after
113.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 8/18/2026 | M · Option Exercise | −9.50K | 135.42 | — | 113.41K |
Common Stock
DirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.51K | Direct |
| Common Stock | 249.11K | Indirect |
| Common Stock | 45.60K | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 166.00 | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |